Skip to content

Fecal Microbiota Transplantation in the treatment of Alzheimer's disease

Fecal Microbiota Transplantation in the treatment of Alzheimer's disease

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100045955
Enrollment
Unknown
Registered
2021-04-30
Start date
2021-04-30
Completion date
Unknown
Last updated
2021-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer‘s disease

Interventions

Sponsors

The First Medical Center, Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1.Aged 50 to 70 years; 2.Patients in mild or moderate state(MMSE > 15/30); 3.Cooperate to complete the inspection; 4.Agree to participate in this study and sign informed consent.

Exclusion criteria

Exclusion criteria: 1.Patients who had cognitive disorder which have relation to metabolic or mental causes; 2.Patients who had severe diseases in kidney, liver, hematological system or had cancer; 3.Patients who have used anti-biotics, probiotics, high-dose vitamins or other therapy regulating gut microbiota.

Design outcomes

Primary

MeasureTime frame
Clinical Dementia Rating;

Secondary

MeasureTime frame
Mini-Mental State Examination;Activity of Daily Living Scale;

Countries

China

Contacts

Public ContactYang Yunsheng

The First Medical Center, Chinese PLA General Hospital

sunnyddc@plagh.org+86 10 55499005

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026